Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2016 (2016), Article ID 7215684, 12 pages
http://dx.doi.org/10.1155/2016/7215684
Research Article

Acute Psychological Stress Modulates the Expression of Enzymes Involved in the Kynurenine Pathway throughout Corticolimbic Circuits in Adult Male Rats

1Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, Canada T2N 4N1
2Mathison Centre for Mental Health Research and Education, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, Canada T2N 4N1
3Department of Neuroscience, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, Canada T2N 4N1
4Department of Cell Biology and Anatomy, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, Canada T2N 4N1
5Department of Psychiatry, Cumming School of Medicine, University of Calgary, 3330 Hospital Drive NW, Calgary, AB, Canada T2N 4N1

Received 6 July 2015; Revised 26 August 2015; Accepted 2 September 2015

Academic Editor: Jordan Marrocco

Copyright © 2016 Haley A. Vecchiarelli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Schwarcz, J. P. Bruno, P. J. Muchowski, and H.-Q. Wu, “Kynurenines in the mammalian brain: when physiology meets pathology,” Nature Reviews Neuroscience, vol. 13, no. 7, pp. 465–477, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Capuron, A. Ravaud, P. J. Neveu, A. H. Miller, M. Maes, and R. Dantzer, “Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy,” Molecular Psychiatry, vol. 7, no. 5, pp. 468–473, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Kohl, T. Walch, R. Huber et al., “Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues,” Journal of Affective Disorders, vol. 86, no. 2-3, pp. 135–142, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. B. E. Leonard and A. Myint, “Changes in the immune system in depression and dementia: causal or coincidental effects?” Dialogues in Clinical Neuroscience, vol. 8, no. 2, pp. 163–174, 2006. View at Google Scholar
  5. M. Maes, R. Verkerk, S. Bonaccorso, W. Ombelet, E. Bosmans, and S. Scharpé, “Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation,” Life Sciences, vol. 71, no. 16, pp. 1837–1848, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. A. H. Miller, S. Ancoli-Israel, J. E. Bower, L. Capuron, and M. R. Irwin, “Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer,” Journal of Clinical Oncology, vol. 26, no. 6, pp. 971–982, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Miura, N. Ozaki, M. Sawada, K. Isobe, T. Ohta, and T. Nagatsu, “A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression,” Stress, vol. 11, no. 3, pp. 198–209, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A.-M. Myint, Y. K. Kim, R. Verkerk, S. Scharpé, H. Steinbusch, and B. Leonard, “Kynurenine pathway in major depression: evidence of impaired neuroprotection,” Journal of Affective Disorders, vol. 98, no. 1-2, pp. 143–151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Swardfager, N. Herrmann, Y. Dowlati et al., “Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease,” Psychoneuroendocrinology, vol. 34, no. 10, pp. 1560–1566, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. A. Zunszain, C. Anacker, A. Cattaneo, L. A. Carvalho, and C. M. Pariante, “Glucocorticoids, cytokines and brain abnormalities in depression,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 3, pp. 722–729, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Leonard and M. Maes, “Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression,” Neuroscience and Biobehavioral Reviews, vol. 36, no. 2, pp. 764–785, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Myint, “Kynurenines: from the perspective of major psychiatric disorders,” The FEBS Journal, vol. 279, no. 8, pp. 1375–1385, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Steiner, B. Bogerts, Z. Sarnyai et al., “Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity,” The World Journal of Biological Psychiatry, vol. 13, no. 7, pp. 482–492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Deak, K. A. Bordner, N. K. McElderry et al., “Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigms,” Brain Research Bulletin, vol. 64, no. 6, pp. 541–556, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Rohleder, “Stimulation of systemic low-grade inflammation by psychosocial stress,” Psychosomatic Medicine, vol. 76, no. 3, pp. 181–189, 2014. View at Publisher · View at Google Scholar
  16. H. A. Vecchiarelli, C. P. Gandhi, J. M. Gray, M. Morena, K. I. Hassan, and M. N. Hill, “Divergent responses of inflammatory mediators within the amygdala and medial prefrontal cortex to acute psychological stress,” Brain, Behavior, and Immunity, 2015. View at Publisher · View at Google Scholar
  17. C. Kiank, J.-P. Zeden, S. Drude et al., “Psychological stress-induced, IDO1-dependent tryptophan catabolism: implications on immunosuppression in mice and humans,” PLoS ONE, vol. 5, no. 7, Article ID e11825, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Miura, Y. Ando, Y. Noda, K. Isobe, and N. Ozaki, “Long-lasting effects of inescapable-predator stress on brain tryptophan metabolism and the behavior of juvenile mice,” Stress, vol. 14, no. 3, pp. 262–272, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Pawlak, Y. Takada, T. Urano, and A. Takada, “Serotonergic and kynurenic pathways in rats exposed to foot shock,” Brain Research Bulletin, vol. 52, no. 3, pp. 197–205, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Cearley, L. Churchill, and J. M. Krueger, “Time of day differences in IL1β and TNFα mRNA levels in specific regions of the rat brain,” Neuroscience Letters, vol. 352, no. 1, pp. 61–63, 2003. View at Publisher · View at Google Scholar
  21. A. Arjona and D. K. Sarkar, “Circadian oscillations of clock genes, cytolytic factors, and cytokines in rat NK cells,” Journal of Immunology, vol. 174, no. 12, pp. 7618–7624, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Nakao, “Temporal regulation of cytokines by the circadian clock,” Journal of Immunology Research, vol. 2014, Article ID 614529, 4 pages, 2014. View at Publisher · View at Google Scholar
  23. M. N. Hill, I. N. Karatsoreos, C. J. Hillard, and B. S. McEwen, “Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo,” Psychoneuroendocrinology, vol. 35, no. 9, pp. 1333–1338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Schwarcz and R. Pellicciari, “Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities,” Journal of Pharmacology and Experimental Therapeutics, vol. 303, no. 1, pp. 1–10, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. H. J. Motulsky and R. E. Brown, “Detecting outliers when fitting data with nonlinear regression—a new method based on robust nonlinear regression and the false discovery rate,” BMC Bioinformatics, vol. 7, article 123, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. C. C. Pritchard, L. Hsu, J. Delrow, and P. S. Nelson, “Project normal: defining normal variance in mouse gene expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 23, pp. 13266–13271, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. U. Alon, “Network motifs: theory and experimental approaches,” Nature Reviews Genetics, vol. 8, no. 6, pp. 450–461, 2007. View at Publisher · View at Google Scholar
  28. J. W. K. Ho, M. Stefani, C. G. dos Remedios, and M. A. Charleston, “Differential variability analysis of gene expression and its application to human diseases,” Bioinformatics, vol. 24, no. 13, pp. i390–i398, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. G. I. Byrne, L. K. Lehmann, J. G. Kirschbaum, E. C. Borden, C. M. Lee, and R. R. Brown, “Induction of tryptophan degradation in vitro and in vivo: a γ-interferon stimulated activity,” Journal of Interferon Research, vol. 6, no. 4, pp. 389–396, 1986. View at Publisher · View at Google Scholar · View at Scopus
  30. A. R. Green, T. L. Sourkes, and S. N. Young, “Liver and brain tryptophan metabolism following hydrocortisone administration to rats and gerbils,” British Journal of Pharmacology, vol. 53, no. 2, pp. 287–292, 1975. View at Publisher · View at Google Scholar
  31. A. Laugeray, J.-M. Launay, J. Callebert, A. Surget, C. Belzung, and P. R. Barone, “Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression,” Behavioural Brain Research, vol. 210, no. 1, pp. 84–91, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Laugeray, J.-M. Launay, J. Callebert, A. Surget, C. Belzung, and P. R. Barone, “Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: focus on individual differences,” Pharmacology Biochemistry and Behavior, vol. 98, no. 1, pp. 161–168, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Rosi, V. Ramirez-Amaya, A. Vazdarjanova, P. F. Worley, C. A. Barnes, and G. L. Wenk, “Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression,” Journal of Neuroscience, vol. 25, no. 3, pp. 723–731, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Sugama, M. Fujita, M. Hashimoto, and B. Conti, “Stress induced morphological microglial activation in the rodent brain: involvement of interleukin-18,” Neuroscience, vol. 146, no. 3, pp. 1388–1399, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. E. S. Wohleb, N. D. Powell, J. P. Godbout, and J. F. Sheridan, “Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior,” The Journal of Neuroscience, vol. 33, no. 34, pp. 13820–13833, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Sibille, Y. Wang, J. Joeyen-Waldorf et al., “A molecular signature of depression in the amygdala,” The American Journal of Psychiatry, vol. 166, no. 9, pp. 1011–1024, 2009. View at Publisher · View at Google Scholar · View at Scopus